MORE►
Dallas biotech
Lantern Pharma CEO Panna Sharma [Courtesy: Lantern Pharma]
Dallas Biotech Launches Open-Access AI Tool Targeting One of Brain Drug Discovery’s Toughest Hurdles
by Quincy Preston | Aug 20, 2025
With just 2% to 6% of small-molecule drugs able to cross the blood-brain barrier, researchers and drugmakers face steep odds. Lantern Pharma’s tool, the company’s CEO says, could be “a paradigm shift” in developing treatments for conditions ranging from brain cancers to Parkinson’s disease.
by Quincy Preston and David Seeley |
Mar 22, 2022
Dallas' status as a growing biotech center got a lift with the official opening of BioLabs, a new coworking space at the Biotech+ Hub at Pegasus Park. The 37,000-square-foot facility offers shared wet labs and office space for up to 35 life science startups.
BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
BioLabs' goal: to serve as the epicenter for life science innovation in North Texas, and to empower biotech trailblazers pursing their next breakthrough.
MORE►
by Quincy Preston and Sandra Engelland |
Feb 18, 2021
The medical device startup developed the Sparrow Therapy System, a wearable neurostimulation device that provides drug-free opioid withdrawal relief. What's next? Spark also has another device in clinical trials to help the youngest victims of addiction—babies. Meet CEO Daniel Powell in our Q+A.
MORE►
by Lauren Hawkins |
Dec 8, 2020
Dallas life science startups are invited to apply to ThinkLab's winter cohort, which will begin in late January 2021.
MORE►
David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Photo: Caris]
Caris Life Sciences Raises $310M to Continue Rapidly Growing in the Precision Medicine Market
by Alex Edwards | Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE►
by Gloria Salinas, Managing Director, Economic Development, DRC |
Oct 1, 2020
Dr. Lynda Stuart of the Bill & Melinda Gates Foundation talked with philanthropist and entrepreneur Lyda Hill in a virtual discussion moderated by Nicole Small, CEO of LH Capital/Lyda Hill Philanthropies.
Here's the takeaway.
Here's the takeaway.
MORE►
![R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]](https://s24806.pcdn.co/wp-content/uploads/2020/04/TayshaGene-Session-970-1-360x203.jpg)
by Quincy Preston and Alex Edwards |
Aug 5, 2020
Taysha Gene Therapies, which was been operating in stealth with UT Southwestern until this April, plans to use the financing to advance its initial cohort of lead programs into its clinic. By the end of 2021, Taysha expects to file four Investigational New Drug applications.
MORE►
